(Q33475480)

27 July 2017

1 reference

title

Biology and treatment of primary central nervous system lymphoma (English)

1 reference

central nervous system lymphoma

27 July 2017

1 reference

primary central nervous system lymphoma

inferred from title

1 reference

2

Cigall Kadoch

1 reference

27 July 2017

Alain P Algazi

1

1 reference

PubMed ID

19560747

27 July 2017

James L Rubenstein

series ordinal

3

1 reference

27 July 2017

1 July 2009

1 reference

27 July 2017

1 reference

27 July 2017

6

1 reference

27 July 2017

3

1 reference

27 July 2017

587-597

1 reference

https://scigraph.springernature.com/pub.10.1016/j.nurt.2009.04.013

27 July 2017

0 references

cites work

Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T(2)-weighted and diffusion-weighted MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Protein biomarker identification in the CSF of patients with CNS lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Temozolomide as salvage treatment in primary brain lymphomas.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Molecular pathogenesis of primary central nervous system lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Gene expression and angiotropism in primary CNS lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Initial experiences of palliative stereotactic radiosurgery for recurrent brain lymphomas

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Delayed neurotoxicity in primary central nervous system lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Pathology and genetics of primary central nervous system and intraocular lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Clinical features and diagnosis of primary central nervous system lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Cognitive status and quality of life after treatment for primary CNS lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Decreasing incidence rates of primary central nervous system lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Distinct primary central nervous system lymphoma defined by comparative genomic hybridization and laser scanning cytometry

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Glucocorticoid treatment of primary CNS lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Epidemiology of primary CNS lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Current management of primary central nervous system lymphoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Primary malignant lymphomas of the central nervous system

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Combined modality therapy for primary CNS lymphoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Primary Central Nervous System Lymphoma

28 July 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Pathway analysis of primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

MRI features of primary central nervous system lymphomas at presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Rituximab for intraocular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Differential gene expression in central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

High-dose methotrexate for intraocular lymphoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

Primary central nervous system lymphoma

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4942275

A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

31 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.013

Failed stereotactic biopsy in a series of 518 cases

21 January 2018

1 reference

12 December 2020

Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of relapsed central nervous system lymphoma with high-dose methotrexate

1 reference

12 December 2020

Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results

1 reference

12 December 2020

PCV salvage chemotherapy for recurrent primary CNS lymphoma

1 reference

12 December 2020

Central nervous system lymphomas in organ allograft recipients

1 reference

12 December 2020

High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

1 reference

12 December 2020

Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients

1 reference

12 December 2020

Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases

1 reference

12 December 2020

Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients

1 reference

12 December 2020

The pharmacokinetics of rituximab following an intravitreal injection

1 reference

12 December 2020

Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system

1 reference

12 December 2020

1 reference

12 December 2020

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

1 reference

12 December 2020

Intraocular levels of methotrexate after intravenous administration

1 reference

12 December 2020

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

1 reference

12 December 2020

Treatment of intraocular lymphoma with high-dose Ara-C

1 reference

12 December 2020

Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications

1 reference

12 December 2020

Long-term survival in primary CNS lymphoma

1 reference

12 December 2020

The role of immunosuppression in lymphoma formation

1 reference

12 December 2020

Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate

1 reference

12 December 2020

Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography

1 reference

12 December 2020

10.1016/J.NURT.2009.04.013

Identifiers

DOI

1 reference

PubMed ID

19560747

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference

PubMed ID

19560747